ToxStrategies, a multidisciplinary scientific consulting firm and a portfolio company of Renovus Capital Partners, has purchased Suttons Creek.
Founded in 2012, Suttons Creek offers consulting and execution services for combination product development across each phase of the product lifecycle. These product development services include quality, regulatory, human factors and usability engineering, strategy consulting, training and education and corporate readiness and executive advising. ToxStrategies partnered with Renovus in November 2022 with the goal of expanding its existing client base and developing new end markets.
“The Suttons Creek team expands and complements our current capabilities to include drug and biologic delivery systems,” comments Laurie Couture Haws, ToxStrategies president. “Suttons Creek offers expert-managed services and consulting that align with ToxStrategies’ mission of delivering unparalleled technical excellence to address our clients’ needs, with a spirit of collaboration and passion for advancing science.”